400
panel
Welcome Reception
panel
The Role of a CEO Amidst a Changing Workforce: Culture, Growth, and Innovation (Invite only)
The Milken Institute has long been focused on how technological disruption is changing the natur
e of work.
+ Read More
panel
Driving Your Data: Personal Control in Finance and Health (Invite only)
Leaders in open banking and open science will discuss ways the movement toward greater data tran
sparency and consumer/patient control is changing data flow and use.
+ Read More
panel
Representation in American Art: Inclusion and Social Change
It is often said that artists mirror society and the political conditions of everyday life in th
eir work, yet looking back, we know that many collections represent the likes of their patrons.
+ Read More
video
Transforming Economies: Investment in MENA
Many MENA economies are prioritizing strategies to diversify away from hydrocarbons and are focusi
ng more attention on advancing solutions that boost the private sector's role for an increasing labor force.
+ Read More
video
Coming of Age: Women Rise to the Top
Over the past decade, traditional power structures in media, movies, and politics have been fundam
entally altered—and intentionally recast.
+ Read More
video
For Women, by Women: Entrepreneurs on the Rise
As the adage goes, "empowered women empower women." From the purchasing power women have as consum
ers to the employment opportunities they offer as business owners, women are an undeniable economic force.
+ Read More
video
Women in Government: Creating More Pathways to Leadership
In 2018, a record number of women ran for Congress, with a majority of Americans indicating they w
ould like to see more women in top leadership positions—not only in elected office, but across executive government positions.
+ Read More
video
Representation in American Art: Inclusion and Social Change
It is often said that artists mirror society and the political conditions of everyday life in thei
r work, yet looking back, we know that many collections represent the likes of their patrons.
+ Read More
video
Getting More From Biomedical Innovation
In 2018 the FDA approved a record number of new products, but pharmaceutical R&D returns have
fallen to their lowest level in nine years.
+ Read More
